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Previewsone such membrane-spanning domain
(Olschewski and Becker, 2008).
The approach by Singla et al. (2011) will
hopefully trigger the synthesis of many
more full-length cell surface receptors,
as they are a highly important class of
proteins in signal transduction and as
drug targets.
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Hormaomycin, an NRPS-produced bacterial metabolite involved in microbial signaling, possesses several
remarkable structural features. The study byHo¨fer et al. (2011) employed a range ofmethodologies to explore
and ultimately understand the elaborate biosynthesis of this complex natural product.Bacteria interact and communicate with
other bacteria in a multitude of ways. For
example, quorum sensing is used to
control density-specific phenotypes that,
in turn, enable behaviors such as biofilm
formation, virulence, or production of anti-
biotics and other secondary metabolites.
Quite often, small autoinducer molecules
such as homoserine lactones, furanosyl
borate diesters, and oligopeptides are
employed to direct these behaviors
by regulating gene expression (Ng and
Bassler, 2009) and, in the case of antibi-
otic production, to activate biosynthetic
gene clusters encoding the production
of additional metabolites that provide
defense for bacteria (El-Sayed et al.,
2001). The effectiveness of these latter
compounds is in part due to their
chemical diversity, as incorporation of
unusual functional groups or elements
such as halogen atoms can increase
both their specificity and biological
activity. Recently, it has become possible
to directly visualize these types of
chemical interactions between bacteriausing MALDI imaging mass spectrometry
(Yang et al., 2009).
In a remarkable paper published in this
issue of Chemistry and Biology, Ho¨fer
et al. (2011) characterize the biosynthesis
of hormaomycin, a highly unusual nonri-
bosomal peptide synthetase (NRPS)-
derived molecule from Streptomyces
griseus. Hormaomycin (also known as
takaokamycin) (Omura et al., 1984) in-
duces morphological differentiation and
secondary metabolite production in acti-
nobacteria, and is also a potent narrow
spectrum antibiotic (MIC 88 pM against
coryneform actinobacteria). Thus, hor-
maomycin is a rare example of a natural
product that can both regulate bacterial
behaviors and also independently func-
tion in a defensive antibiotic role.
Hormaomycin is composed of several
unusual residues, making it quite possibly
the most structurally unique microbial
morphogen yet described. Most dramati-
cally, it possesses two alanine residues
with nitro-cyclopropyl groups [(3-Ncp)
Ala], two b-methyl phenylalanine resi-dues [(b-Me)Phe], a novel chlorinated
pyrrole [5-chloropyrrole 2-carboxylic
acid (Chpca)], and a proline unit with a
4-propenyl substituent [4-((Z)-propenyl)
proline (4(-Pe)Pro)] (Figure 1). Although
the structure of hormaomycin has been
confirmed via total synthesis, insights
into its biosynthesis have until now been
limited to feeding experiments focused
on the two unusual (3-Ncp)Ala residues
and have revealed their ultimate origin
from L-lysine (Brandl et al., 2005). Addi-
tional prior work revealed that alternate
precursor amino acids could be incorpo-
rated into this unit, producing a hormao-
mycin analog with altered biological
properties (activity against the fungus
Candida albicans) (Zlatopolskiy et al.,
2006). One other study identified the
pyrrole halogenase from this gene cluster
(ultimately HrmQ) and demonstrated that
it could be inserted into the chlorobiocin
biosynthetic pathway in Streptomyces
roseochromogenes var. oscitans, thereby
producing two novel analogs (Heide et al.,
2008).ª2011 Elsevier Ltd All rights reserved 281
Figure 1. Biosynthetic Origin of Hormaomycin Residues as Determined by Ho¨fer et al.
(b-Me)Phe: b-methyl phenylalanine (blue); (3-Ncp)Ala: 3-(trans-20-nitrocyclopropyl)alanine (red); Chpca: 5-chloropyrrole 2-carboxylic acid (green); 4(-Pe)Pro:
4-((Z)-propenyl) proline (purple). Putative enzyme functions are shown with each predicted biosynthetic reaction.
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PreviewsIn this new work, Ho¨fer et al. (2011) first
conduct a series of isotope-labeled pre-
cursor studies to gain insight into the
metabolic building blocks for hormaomy-
cin and then use the resulting knowledge
of adenylation domain specificity coupled
with the previously characterized halo-
genase to efficiently clone and sequence
the 48.4 Kb biosynthetic gene cluster.
A detailed bioinformatic analysis of the
hormaomycin gene cluster provided crit-
ical insights into putative mechanisms
involved in constructing this unique mole-
cule. For example, the pathway is quite
specific for the starter unit, 5-chloropyr-
role, and provision of pyrrole-2-carbox-
ylate to cultures enhanced hormaomycin
yields 4 fold. The products of five genes,
hrmKLMNQ, are proposed to form the
Chpca group (green structure in Figure 1)
from proline, based on homology with
related genes involved in chlorinated
pyrrole formation. To investigate the
origin of the (b-Me)Phe moieties (blue),
feeding studies first demonstrated
phenylalanine incorporation and S-ad-
enosyl methionine (SAM)-dependent
methylation. By homology reasoning,282 Chemistry & Biology 18, March 25, 2011HrmSwas identified as the putative meth-
yltransferase and likely adds the methyl
group to the a-keto acid phenyllactate;
lack of an aminotransferase in the gene
cluster suggests use of an aminotrans-
ferase from primary metabolism. Pre-
cursor feedings with p-fluoro-Phe led to
the production of novel hormaomycin
analogs that lacked one or both of the
b-methyl groups of the two b-methyl-
Phe residues, suggesting that this fluori-
nated analog functions as a selective
inhibitor of the methyltransferase. Next,
the authors’ analysis suggested that tyro-
sine is incorporated and modified by
HrmC-G to produce the (4-Pe)Pro residue
(purple). HrmF is suspected to be involved
in the dioxygenase cleavage of dihydrox-
yphenylalanine (DOPA), itself produced
by action of HrmE on tyrosine. Expression
of HrmF and biochemical characterization
demonstrated its robust catalytic effi-
ciency in cleaving DOPA to a dihydropyr-
role intermediate. Subsequent transfor-
mations are less certain but at some
stage involve a unique terminal methyla-
tion by SAM, a result also indicated by
13C-labeled precursor feeding studies.ª2011 Elsevier Ltd All rights reservedThe genes encoding the biosynthetic
proteins forming the intriguing (3-Ncp)
Ala groups (red) remain unknown but, by
process of elimination, appear to involve
hrmIJ, two genes with no characterized
homologs that are the subject of
continuing biochemical study by the Piel
laboratory. What is clear, and clearly
exciting, is that the formation of the
cyclopropyl rings in these two residues
occurs by a process unlike any currently
described.
This studybyHo¨feretal. (2011) elegantly
examines the mechanisms involved in
creating chemical diversity in an excep-
tionally complex natural product, hormao-
mycin. The article not only explores
how these compounds are made, but
an analysis of the gene cluster also uncov-
ered intriguing evolutionary insights into
the pathway. The hormaomycin gene
cluster possesses regions with very high
sequence identity shared between adeny-
lation domains, with the only differences
occurring within the amino acid specificity
pockets. This suggests that recombinato-
rial swapping of short DNA regions encod-
ing substrate specificity is sufficient to
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derived natural products, and thus entire
domain or module exchanges are not
necessarily required for pathway evolu-
tion. Furthermore, some hormaomycin
biosynthetic enzymes are promiscuous,
allowing for theprecursor-directedbiosyn-
thesis of analogs with varied biological
activity and demonstrating the promise of
this pathway to engineer new bioactive
molecules.
In summary, hormaomycin is a fascinat-
ingly complex bacterial signaling mole-
cule and antibiotic. A wonderful interplay
of isotope-labeled precursor feeding
experiments, analytical chemistry, bio-
synthetic gene cluster identification, bio-
informatics, protein expression, andbiochemical characterization were used
to unravel this puzzle andmake its biosyn-
thesis comprehensible. The confluence of
these approaches provided keen insights
of various methods by which to pro-
duce analog structures and engineer the
pathway, ultimately harnessing bacterial
communication to make valuable contri-
butions to pharmaceutical biotechnology.REFERENCES
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